Antigen specificity acquisition of adoptive CD4+ regulatory T cells via acquired peptide-MHC class I complexes

Journal of Immunology

Volumn 181, Issue 4, 2008, Pages 2428-2437

  Hao, Siguo ^a   Yuan, Jinying ^a   Xu, Shulin ^a   Munegowda, Manjunatha Ankathatti ^a   Deng, Yulin ^a   Gordon, John ^b   Xing, Zhou ^c   Xiang, Jim ^a,d  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Saskatoon Cancer Center   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; EPITOPE; H 2KB PROTEIN, MOUSE; H-2KB PROTEIN, MOUSE; H2 ANTIGEN; HY ANTIGEN; PEPTIDE; PROTEIN; UTY PROTEIN, MOUSE;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; EXOSOME; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TARGET CELL; TRANSGENIC MOUSE; TUMOR IMMUNITY; ADOPTIVE TRANSFER; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL DIFFERENTIATION; CROSS PRESENTATION; CYTOLOGY; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; TIME; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CROSS-PRIMING; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; GRAFT VS HOST DISEASE; H-2 ANTIGENS; H-Y ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; PEPTIDES; PROTEINS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS;

EID: 53149113821     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.4.2428     Document Type: Article

References (46)

1. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
2. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
3. + regulatory T cells. J. Immunol. 171: 5678-5682.
4. + regulatory T cells is antigen-specific and requires IL-10 and TGF-β. J. Immunol. 175: 4283-4291.
5. + regulatory T cell function in alloimmunity. J. Immunol. 176: 329-334.
6. h2 shift. Int. Immunol. 12: 623-630.
7. McGuirk, P., C. McCann, and K. H. Mills. 2002. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J. Exp. Med. 195: 221-231.
8. + regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118.
9. + regulatory T cells in cancer: implications for immunotherapy. Microbes Infect. 7: 1056-1062.
10. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 99: 8213-8218.
11. Scalapino, K. J., Q. Tang, J. A. Bluestone, M. L. Bonyhadi, and D. I. Daikh. 2006. Suppression of disease in New Zealand Black/New Zealand White lupusprone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol. 177: 1451-1459.
12. Huang, J. F., Y. Yang, H. Sepulveda, W. Shi, I. Hwang, P. A. Peterson, M. R. Jackson, J. Sprent, and Z. Cai. 1999. TCR-mediated internalization of peptide-MHC complexes acquired by T cells. Science 286: 952-954.
13. Hwang, I., J. F. Huang, H. Kishimoto, A. Brunmark, P. A. Peterson, M. R. Jackson, C. D. Surh, Z. Cai, and J. Sprent. 2000. T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J. Exp. Med. 191: 1137-1148.
14. + T cell acquisition of the bystander pMHC I colocalizing in the same immunological synapse comprising pMHC II and costimulatory CD40, CD54, CD80, OX40L, and 41BBL. Biochem. Biophys. Res. Commun. 362: 822-828.
15. + T helper-antigen-presenting cells. J. Immunol. 174: 7497-7505.
16. + T cell expansion via acquired pMHC I complexes and costimulatory molecules, and IL-2 secretion. J. Leukocyte Biol. 80: 1354-1363.
17. Faulkner, L., G. Buchan, and M. Baird. 2000. Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation. Immunology 99: 523-531.
18. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
19. Kim, S. H., E. R. Lechman, N. Bianco, R. Menon, A. Keravala, J. Nash, Z. Mi, S. C. Watkins, A. Gambotto, and P. D. Robbins. 2005. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J. Immunol. 174: 6440-6448.
20. Mitchell, D. A., S. K. Nair, and E. Gilboa. 1998. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells. Eur. J. Immunol. 28: 1923-1933.
21. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6: 715-726.
22. Xing, Z., Y. Ohkawara, M. Jordana, F. L. Graham, and J. Gauldie. 1997. Adenoviral vector-mediated interleukin-10 expression in vivo: intramuscular gene transfer inhibits cytokine responses in endotoxemia. Gene Ther. 4: 140-149.
23. Zhang, W., Z. Chen, F. Li, H. Kamencic, B. Juurlink, J. R. Gordon, and J. Xiang. 2003. Tumour necrosis factor-α (TNF-α) transgene-expressing dendritic cells (DCs) undergo augmented cellular maturation and induce more robust T-cell activation and anti-tumour immunity than DCs generated in recombinant TNF-α. Immunology 108: 177-188.
24. Hao, S., O. Bai, F. Li, J. Yuan, S. Laferte, and J. Xiang. 2007. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology 120: 90-102.
25. + regulatory T cells. Transplantation 82: 1749-1755.
26. + regulatory T cell-mediated suppression. J. Immunol. 176: 3900-3904.
27. + T cell responses via acquired peptide-MHC class I complexes and CD80 costimulation, and IL-2 secretion. J. Immunol. 177: 2976-2984.
28. Battaglia, M., S. Gregori, R. Bacchetta, and M. G. Roncarolo. 2006. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18: 120-127.
29. + T regulatory 1 cells to suppress antitumor immunity. J. Immunol. 175: 2931-2937.
30. + T cells derived from in vitro dendritic cell activation. Int. Immunol. 18: 887-895.
31. + CTL responses. J. Immunol. 179: 2731-2740.
32. Zhang, Z. X., L. Yang, K. J. Young, B. DuTemple, and L. Zhang. 2000. Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat. Med. 6: 782-789.
33. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164: 183-190.
34. + immunoregulatory cells. J. Immunol. 167: 1137-1140.
35. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 193: 1295-1302.
36. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188: 287-296.
37. + and NK lymphocytes in the direct cell-to-cell interaction. Clin. Immunol. 112: 258-267.
38. + T helper cells. J. Exp. Med. 196: 255-260.
39. + T cell clonal anergy induction during the recovery from lymphopenia. J. Immunol. 176: 5880-5889.
40. - T cells anergic and suppressive. Immunology 120: 447-455.
41. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol. 30: 1538-1543.
42. Munn, D. H., M. D. Sharma, J. R. Lee, K. G. Jhaver, T. S. Johnson, D. B. Keskin, B. Marshall, P. Chandler, S. J. Antonia, R. Burgess, et al. 2002. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870.
43. Seewaldt, S., J. Alferink, and I. Forster. 2002. Interleukin-10 is crucial for maintenance but not for developmental induction of peripheral T cell tolerance. Eur. J. Immunol. 32: 3607-3616.
44. Sharif, O., V. N. Bolshakov, S. Raines, P. Newham, and N. D. Perkins. 2007. Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunol. 8: 1-17.
45. Joss, A., M. Akdis, A. Faith, K. Blaser, and C. A. Akdis. 2000. IL-10 directly acts on T cells by specifically altering the CD28 co-stimulation pathway. Eur. J. Immunol. 30: 1683-1690.
46. + regulatory T cells exhibit comparable suppression to OVA mediated T cell responses. Cell. Immunol. 241: 75-84.